128 related articles for article (PubMed ID: 37641811)
1. Inhibition of the interaction between Hippo/YAP and Akt signaling with ursolic acid and 3'3-diindolylmethane suppresses esophageal cancer tumorigenesis.
Meng RY; Li CS; Hu D; Kwon SG; Jin H; Chai OH; Lee JS; Kim SM
Korean J Physiol Pharmacol; 2023 Sep; 27(5):493-511. PubMed ID: 37641811
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
[TBL] [Abstract][Full Text] [Related]
3. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
4. Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer.
Kim SH; Jin H; Meng RY; Kim DY; Liu YC; Chai OH; Park BH; Kim SM
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547587
[TBL] [Abstract][Full Text] [Related]
5. YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy.
Qian X; He L; Hao M; Li Y; Li X; Liu Y; Jiang H; Xu L; Li C; Wu W; Du L; Yin X; Lu Q
Acta Diabetol; 2021 Jan; 58(1):47-62. PubMed ID: 32816106
[TBL] [Abstract][Full Text] [Related]
6. 3,3'-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway.
Li XJ; Park ES; Park MH; Kim SM
Oncol Rep; 2013 Nov; 30(5):2419-26. PubMed ID: 24008339
[TBL] [Abstract][Full Text] [Related]
7. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade.
Meng RY; Jin H; Nguyen TV; Chai OH; Park BH; Kim SM
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768915
[TBL] [Abstract][Full Text] [Related]
8. Regulation of YAP through an Akt-dependent process by 3, 3'-diindolylmethane in human colon cancer cells.
Li XJ; Leem SH; Park MH; Kim SM
Int J Oncol; 2013 Dec; 43(6):1992-8. PubMed ID: 24100865
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
10. The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation.
Wang W; Huang Q; Chen Y; Huang Z; Huang Y; Wang Y; Qi X; Liu Z; Lu L
Pharmacol Res; 2021 Aug; 170():105723. PubMed ID: 34116210
[TBL] [Abstract][Full Text] [Related]
11. C21 steroid-enriched fraction refined from
Zhang Y; Li K; Ying Y; Chen B; Hao K; Chen B; Zheng Y; Lyu J; Tong X; Chen X; Wang Y; Zhan Z; Zhang W; Wang Z
Oncotarget; 2017 Dec; 8(66):110576-110591. PubMed ID: 29299170
[No Abstract] [Full Text] [Related]
12. Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer.
Jeong SH; Kim HB; Kim MC; Lee JM; Lee JH; Kim JH; Kim JW; Park WY; Kim SY; Kim JB; Kim H; Kim JM; Choi HS; Lim DS
J Clin Invest; 2018 Mar; 128(3):1010-1025. PubMed ID: 29400692
[TBL] [Abstract][Full Text] [Related]
13. The neuroprotective effects of Insulin-Like Growth Factor 1 via the Hippo/YAP signaling pathway are mediated by the PI3K/AKT cascade following cerebral ischemia/reperfusion injury.
Gong P; Zou Y; Zhang W; Tian Q; Han S; Xu Z; Chen Q; Wang X; Li M
Brain Res Bull; 2021 Dec; 177():373-387. PubMed ID: 34717965
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1.
Fan R; Kim NG; Gumbiner BM
Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2569-74. PubMed ID: 23359693
[TBL] [Abstract][Full Text] [Related]
15. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.
Wang C; Gu C; Jeong KJ; Zhang D; Guo W; Lu Y; Ju Z; Panupinthu N; Yang JY; Gagea MM; Ng PK; Zhang F; Mills GB
Cancer Res; 2017 Apr; 77(7):1637-1648. PubMed ID: 28202507
[TBL] [Abstract][Full Text] [Related]
16. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
[TBL] [Abstract][Full Text] [Related]
17. NGF Signaling Interacts With the Hippo/YAP Pathway to Regulate Cervical Cancer Progression.
Wang L; Li J; Wang R; Chen H; Wang R; Wang W; Yang X
Front Oncol; 2021; 11():688794. PubMed ID: 34722240
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation.
Grosbois J; Demeestere I
Hum Reprod; 2018 Sep; 33(9):1705-1714. PubMed ID: 30032281
[TBL] [Abstract][Full Text] [Related]
19. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
Zhang LN; Zhao L; Yan XL; Huang YH
J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
[TBL] [Abstract][Full Text] [Related]
20. Insulin receptor substrate 2: a bridge between Hippo and AKT pathways.
Jeong SH; Lim DS
BMB Rep; 2018 May; 51(5):209-210. PubMed ID: 29699606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
